11,313 confirmed cases and 23 deaths in 2025 compared to 358 cases in 2024. The Americas region, the only part of the world to have eliminated measles in 2016, is seeing the disease resurge with a 31-fold increase in cases in a single year. This regression exposes the disastrous economic equation of vaccine hesitancy in prosperous societies.
The collapse of a unique global health success reveals the cost of vaccine inaction. Canada and Mexico concentrate the most active outbreaks, particularly affecting unvaccinated communities. This avoidable health crisis questions the capacity of Western democracies to maintain their gains in the face of anti-vaccine movements.
The Essentials
- 11,313 confirmed measles cases in 2025 compared to 358 in 2024, a 31-fold increase
- 23 deaths recorded, primarily among children under 5 years old
- Canada and Mexico account for 67% of new cases
- The Americas had eliminated measles in 2016, the first region in the world to achieve this
- The region’s vaccination coverage was 89% (first dose) and 79% (second dose) in 2024, well below the 95% threshold necessary for herd immunity
Canada Concentrates Half of New Cases Despite Its Health Wealth
4,982 confirmed cases in Canada represent 44% of the continental epidemic. The province of Alberta alone accounts for 2,847 infections, followed by British Columbia with approximately 360 cases. This geographic concentration reveals the impact of religious communities resistant to vaccination in Canada’s western provinces.
The economic cost has already exceeded 180 million Canadian dollars according to Health Canada, including hospitalizations, contact isolation, and emergency campaigns. Each measles case requires an average of 12,000 dollars in public spending to contain transmission, compared to 2 dollars for a single MMR vaccine dose.
Amish and Mennonite communities in Alberta show vaccination rates below 40%. These pockets of vulnerability allow the virus to circulate freely, threatening fragile populations including infants under 12 months and immunocompromised persons.
Mexico Suffers Its Worst Epidemic Since 2016 Elimination
2,634 Mexican cases place the country in second place on the continent, with particularly high mortality: 14 of the 23 regional deaths. The State of Chiapas concentrates 1,892 infections, heavily affecting rural and indigenous populations where vaccine access remains limited.
Mexican vaccination coverage dropped from 96% in 2019 to 89% in 2024 according to the Pan American Health Organization. This erosion results from a combination of logistical difficulties in remote areas and growing vaccine distrust amplified by social networks.
The government of Claudia Sheinbaum deployed 2,400 mobile vaccination teams in states bordering Guatemala and Belize, where cross-border migration facilitates viral spread. This emergency response mobilizes 340 million pesos, equivalent to 400 preventive vaccination campaigns.
The United States Resists Better Thanks to Its Regulatory Arsenal
2,242 confirmed cases in the United States in 2025 keep the country at the lowest critical levels, despite the presence of active outbreaks in Florida, Texas, and California. This relative performance is explained by stricter school vaccination requirements than those of its northern neighbors.
Forty-five U.S. states impose MMR vaccination for entry into public school, with religious exemptions limited to five states. This regulatory architecture maintains national coverage at 94.9%, close to the critical 95% threshold required for herd immunity.
The cost of the American epidemic nonetheless reaches 89 million dollars according to the Centers for Disease Control and Prevention. New York alone mobilizes 34 million to contain the Brooklyn outbreak, where Orthodox communities show vaccination rates below 60%.
Measles Tests the Health Resilience of Prosperous Democracies
This resurgence is part of a troubling global trend. Global measles cases increased 79% between 2023 and 2024 according to the WHO, primarily affecting high-income countries where vaccine complacency is setting in.
Epidemics are becoming commonplace and the world refuses to adapt to them, revealing collective fatigue with preventive health measures. This weariness finds fertile ground in prosperous societies where preventable diseases seem to belong to the past.
Yet the economic equation remains unambiguous: every dollar invested in MMR vaccination generates 44 dollars in savings in avoided medical and social costs. This exceptional return on investment explains why measles elimination was such a precious achievement for the Americas.
The battle to reclaim herd immunity promises to be long. Experts estimate it will take three to five years of intensive campaigns to restore 2019 coverage levels. In the meantime, each epidemic will cost hundreds of millions and expose the most vulnerable to a perfectly preventable disease.